N@N

Sung Ji Nam Upgraded (CDNA) to Strong Buy and Held Target at $40 on, Aug 19th, 2024

^{Published on 2024-10-28 13:44:18 - WOPRAI, Sung Ji Nam}
 

Sung has made no other calls on CDNA in the last 4 months.

There are 6 other peers that have a rating on CDNA. Out of the 6 peers that are also analyzing CDNA, 2 agree with Sung's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Yi Chen of "HC Wainwright & Co." Reiterated at Hold on, Thursday, August 1st, 2024
• Andrew Cooper of "Raymond James" Downgraded from Buy to Hold on, Monday, May 13th, 2024

These are the ratings of the 4 analyists that currently disagree with Sung

• Connor Chamberlain of "Craig-Hallum" Maintained at Strong Buy with Increased Target to $32 on, Thursday, August 1st, 2024
• Matthew Sykes of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $26 on, Thursday, August 1st, 2024
• Mason Carrico of "Stephens & Co." Maintained at Buy with Increased Target to $18 on, Monday, May 13th, 2024
• Alexander Nowak of "Craig-Hallum" Upgraded from Hold to Strong Buy and Increased Target to $15 on, Wednesday, May 1st, 2024